The US Food and Drug Administration-European Medicines Agency Collaboration in Pharmacovigilance: Common Objectives and Common Challenges
The US Food and Drug Administration-European Medicines Agency Collaboration in Pharmacovigilance: Common Objectives and Common Challenges
复制标题
DOI：
10.1007/s40264-014-0259-3
复制
发表时间：
2015-01-01
期刊：
影响因子：
4.2
通讯作者：
Arlett, Peter R.
中科院分区：
文献类型：
--
作者：
Dal Pan, Gerald J.;Arlett, Peter R.
2014年2月19日，美国食品和药物管理局（FDA）和欧洲药品管理局（EMA）宣布成立一个药物警戒专题集群。这一组的目的是补充而不是取代这一领域的其他国际活动。它建立在两个机构多年来的互动基础上。集群的创建使这种长期和富有成效的关系正式化，并促进了更系统的信息和专业知识交流。
On 19 February 2014, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) announced the formation of a cluster on pharmacovigilance topics. The cluster is designed to complement, and not replace, other international activities in this field. It builds upon years of interactions between the two agencies. The creation of the cluster formalizes this longstanding and productive relationship and facilitates more systematic exchange of information and expertise.